From: A study of the role of GATA4 polymorphism in cardiovascular metabolic disorders
 | Controls | Cases | ||||
---|---|---|---|---|---|---|
 | All | Male | Female | All | Male | Female |
Gender | 2,004 | 1,074 (53.6) | 930 (46.4) | 2,274 | 1,736 (76.3) | 538 (23.7) |
Age | 50.2 ± 0.5 | 50.81 ± 0.5 | 49.66 ± 0.5 | 60.8 ±0.4 | 59.7 ± 0.3 | 61.8 ± 0.5 |
BMI | 29.4 ±0.2 | 28.01 ± 0.2 | 30.69 ± 0.2 | 29.7 ± 0.2 | 28.3 ± 0.1 | 31.1 ± 0.3 |
MI | 1,388 | 684 (0.49) | 704 (0.51) | 2,890 | 2,126 (0.74) | 764 (0.26) |
T2DM | 1,900 | 1,220 (0.64) | 680 (0.36) | 2,378 | 1,590 (0.67) | 788 (0.33) |
HTN | 966 | 650(0.67) | 314 (0.33) | 3,312 | 2,158 (0.65) | 1,154 (0.35) |
lHDLC | 2,209 | 1,262 (0.57) | 947 (0.43) | 1,776 | 1,371 (0.77) | 405 (0.23) |
hLDL | 3,404 | 2,267 (0.67) | 1,137 (0.33) | 575 | 364 (0.63) | 211 (0.37) |
hTG | 2,896 | 1,859 (0.64) | 1,037 (0.36) | 1,088 | 773 (0.71) | 315 (0.29) |
hChol | 2,487 | 1,639 (0.66) | 848 (0.34) | 1,590 | 1,051 (0.66) | 539 (0.34) |
CHD | 4,128 | 2,741 (0.66) | 1,387 (0.34) | 150 | 69 (0.46) | 81 (0.54) |
FH | 3,421 | 2,255 (0.66) | 1,166 (0.34) | 857 | 555 (0.65) | 302 (0.35) |
OBS | 2,362 | 1,729 (0.73) | 633 (0.27) | 1,631 | 895 (0.55) | 736 (0.45) |
Smokers | 2,575 | 1,223 (0.47) | 1,352 (0.53) | 1,619 | 1,547 (0.96) | 72 (0.04) |
VD | Â | Â | Â | Â | Â | Â |
 One | 0 | 0 | 0 | 847 | 614 (0.72) | 233 (0.28) |
 Two | 0 | 0 | 0 | 456 | 355 (0.78) | 101 (0.22) |
 More than two | 0 | 0 | 0 | 971 | 767 (0.79) | 204 (0.21) |